Home Featured 2

Featured 2

Featured posts

Most popular

Financial Incentives and Free Treatment Aids for Smoking Cessation in the Workplace

lungcanc

Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC

IASLC Journals Share Exciting Milestones on Metrics Journeys

Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with Dr. Shirish Gadgeel

Histologic Transformation From NSCLC to SCLC: A Mechanism of Resistance to Osimertinib and Other Agents Targeting EGFR Mutations

Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?

lungcanc

Timing of Immune Checkpoint Inhibitors With Respect to Molecular Testing in...

lungcanc

Understanding the Effects of Time to Surgery on Upstaging for Stage...

lungcanc

Treating Patients with MET Alterations: A Q&A with Dr. Ravi Salgia

lungcanc

Ireland’s Complex Healthcare System and Its Relation to Innovative Ways for...

lungcanc

Expanding Efforts Help Address Disparities in Lung Cancer Care

lungcanc

Ongoing Clinical Challenges: Defining Immunotherapy Benefit for Patients With NSCLC and...

lungcanc

SHAWL: Largest Study of Its Kind Evaluates Sexual Dysfunction in Women...

lungcanc

ICU Care for the Patient with Lung Cancer

lungcanc

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: A Q&A With Dr....

lungcanc

12 3...7 Page 1 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib